Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties

Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties

US Patent 6846802 · Granted Jan 25, 2005

Estimated economic value: $135,519,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matriptase 2 inhibitors and uses thereof2025
Anti-influenza virus pyrimidine derivatives2025
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors a2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
Anti-influenza virus pyrimidine derivative2023
Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl2023
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors2023
Crystal form and salt form of pyridoimidazole compound and preparation method th2022
Bicylic compound acting as an inhibitor2022
Borate of azetidine derivative2022